Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Eugen Ruckhäberle"'
Autor:
Janna Morawitz, Nils-Martin Bruckmann, Kai Jannusch, Frederic Dietzel, Aleksandar Milosevic, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Lena Häberle, Wolfgang Peter Fendler, Ken Herrmann, Frederik Lars Giesel, Gerald Antoch, Lale Umutlu, Bernd Kowall, Andreas Stang, Julian Kirchner
Publikováno v:
Cancers, Vol 15, Iss 14, p 3646 (2023)
Background: This study compares the diagnostic potential of conventional staging (computed tomography (CT), axillary sonography and bone scintigraphy), whole-body magnetic resonance imaging (MRI) and whole-body 18F-fluorodeoxyglucose positron emissio
Externí odkaz:
https://doaj.org/article/2f0be3f23a294af7a093795ecf48c00e
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Studies have shown that perioperative music interventions can reduce patients’ anxiety levels. However, in small operations like port catheter surgery evidence is sparse. The present single-blinded, randomised controlled two-armed study in
Externí odkaz:
https://doaj.org/article/8e2032879cf54c6aa07e3f2841edb6bb
Autor:
Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W. Beckmann, Erik Belleville, Peter A. Fasching, Tanja N. Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji, Andreas D. Hartkopf, Carsten Hielscher, Jens Huober, Eugen Ruckhäberle, Wolfgang Janni, Hans Christian Kolberg, Christian M. Kurbacher, Evelyn Klein, Michael P. Lux, Volkmar Müller, Naiba Nabieva, Friedrich Overkamp, Hans Tesch, Elena Laakmann, Florin-Andrei Taran, Julia Seitz, Christoph Thomssen, Michael Untch, Pauline Wimberger, Rachel Wuerstlein, Bernhard Volz, Diethelm Wallwiener, Markus Wallwiener, Sara Y. Brucker
Publikováno v:
Breast, Vol 54, Iss , Pp 88-95 (2020)
Purpose: Treatment with CDK4/6 inhibitors and endocrine therapy (CDK4/6i + ET) is a standard for patients with advanced hormone receptor–positive, HER2-negative (HR + HER2–) breast cancer (BC). However, real-world data on the implementation of th
Externí odkaz:
https://doaj.org/article/06b4953fd7094428a800955c7f592096
Autor:
Hannah Asperger, Nadia Stamm, Berthold Gierke, Michael Pawlak, Ute Hofmann, Ulrich M. Zanger, Annamaria Marton, Robert L. Katona, Andrea Buhala, Csaba Vizler, Jan-Philipp Cieslik, Eugen Ruckhäberle, Dieter Niederacher, Tanja Fehm, Hans Neubauer, Marina Ludescher
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-16 (2020)
Abstract Background PGRMC1 (progesterone receptor membrane component 1) is a highly conserved heme binding protein, which is overexpressed especially in hormone receptor-positive breast cancer and plays an important role in breast carcinogenesis. Nev
Externí odkaz:
https://doaj.org/article/42355fde8ab24dab8270e6055c485100
Autor:
Natalia Krawczyk, Melissa Neubacher, Franziska Meier-Stiegen, Hans Neubauer, Dieter Niederacher, Eugen Ruckhäberle, Svjetlana Mohrmann, Jürgen Hoffmann, Thomas Kaleta, Malgorzata Banys-Paluchowski, Petra Reinecke, Irene Esposito, Wolfgang Janni, Tanja Fehm
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The prognostic relevance of circulating tumour cells (CTCs) in metastatic breast cancer (MBC) patients has been confirmed by several clinical trials. However, predictive blood-based biomarkers for stratification of patients for ta
Externí odkaz:
https://doaj.org/article/bee6175fb734497e840ea4409f1dae58
Autor:
Jan Haussmann, Wilfried Budach, Carolin Nestle-Krämling, Sylvia Wollandt, Balint Tamaskovics, Stefanie Corradini, Edwin Bölke, David Krug, Tanja Fehm, Eugen Ruckhäberle, Werner Audretsch, Danny Jazmati, Christiane Matuschek
Publikováno v:
Cancers, Vol 14, Iss 16, p 4031 (2022)
Background: Neoadjuvant radiotherapy (naRT) in addition to neoadjuvant chemotherapy (naCT) has been used for locally advanced, inoperable breast cancer or to allow breast conserving surgery (BCS). Retrospective analyses suggest that naRT + naCT might
Externí odkaz:
https://doaj.org/article/6b1d39d908f74174a2754b544935d443
Autor:
Danny Jazmati, Edwin Bölke, Kati Halfmann, Bálint Tamaskovics, Eugen Ruckhäberle, Tanja Fehm, Jürgen Hoffmann, David Krug, Carolin Nestle Krämling, Stefanie Corradini, Wilfried Budach, Svjetlana Mohrmann, Jan Haussmann, Christiane Matuschek
Publikováno v:
Cancers, Vol 14, Iss 15, p 3636 (2022)
Background/Aims: Due to its favorable dose distribution and targeting of the region at highest risk of recurrence due to direct visualization of tumor bed, intraoperative electron radiation therapy (IOERT) is used as part of a breast-conserving treat
Externí odkaz:
https://doaj.org/article/b01b222fb8fa4de580e87f4898906bbf
Autor:
Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Gerald Antoch, Saskia Ting, Ann-Kathrin Bittner, Oliver Hoffmann, Lena Häberle, Eugen Ruckhäberle, Onofrio Antonio Catalano, Michal Chodyla, Johannes Grueneisen, Harald H. Quick, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Peter Gibbs, Katja Pinker
Publikováno v:
Cancers, Vol 14, Iss 7, p 1727 (2022)
Background: The aim of this study was to assess whether multiparametric 18F-FDG PET/MRI-based radiomics analysis is able to predict pathological complete response in breast cancer patients and hence potentially enhance pretherapeutic patient stratifi
Externí odkaz:
https://doaj.org/article/1f92b4840d364cf7a627c7b577851702
Autor:
Christiane Matuschek, Danny Jazmati, Edwin Bölke, Bálint Tamaskovics, Stefanie Corradini, Wilfried Budach, David Krug, Svjetlana Mohrmann, Eugen Ruckhäberle, Tanja Fehm, Carolin Nestle Krämling, Markus Dommach, Jan Haussmann
Publikováno v:
Cancers, Vol 14, Iss 5, p 1246 (2022)
Neoadjuvant chemotherapy enables close monitoring of tumor response in patients with breast cancer. Being able to assess tumor response during treatment provides an opportunity to evaluate new therapeutic strategies. Thus, for triple-negative breast
Externí odkaz:
https://doaj.org/article/f63b03fde1694d748ff0bab4fa567ed1
Autor:
Yingxue Bai, Marina Ludescher, Gereon Poschmann, Kai Stühler, Martine Wyrich, Julia Oles, André Franken, Mahdi Rivandi, Anna Abramova, Florian Reinhardt, Eugen Ruckhäberle, Dieter Niederacher, Tanja Fehm, Michael A. Cahill, Nadia Stamm, Hans Neubauer
Publikováno v:
Cancers, Vol 13, Iss 22, p 5635 (2021)
In previous studies, we reported that progesterone receptor membrane component 1 (PGRMC1) is implicated in progestin signaling and possibly associated with increased breast cancer risk upon combined hormone replacement therapy. To gain mechanistic in
Externí odkaz:
https://doaj.org/article/6a9e08196bd446198cfebd6c4010e315